116 related articles for article (PubMed ID: 27802193)
21. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
22. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
[TBL] [Abstract][Full Text] [Related]
23. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
Nassir M; Guan J; Luketina H; Siepmann T; Rohr I; Richter R; Castillo-Tong DC; Zeillinger R; Vergote I; Van Nieuwenhuysen E; Concin N; Marth C; Hall C; Mahner S; Woelber L; Sehouli J; Braicu EI
Tumour Biol; 2016 Mar; 37(3):3009-16. PubMed ID: 26419591
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
[TBL] [Abstract][Full Text] [Related]
25. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
Pylväs-Eerola M; Karihtala P; Puistola U
BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
[TBL] [Abstract][Full Text] [Related]
26. Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies.
Jóźwik M; Okungbowa OE; Lipska A; Jóźwik M; Smoktunowicz M; Semczuk A; Jóźwik M; Radziwon P
BMC Cancer; 2015 Mar; 15():129. PubMed ID: 25880896
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery.
Ataseven B; du Bois A; Reinthaller A; Traut A; Heitz F; Aust S; Prader S; Polterauer S; Harter P; Grimm C
Gynecol Oncol; 2015 Sep; 138(3):560-5. PubMed ID: 26163893
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based Chemotherapy.
Miao Y; Li S; Yan Q; Li B; Feng Y
Oncol Res Treat; 2016; 39(11):712-719. PubMed ID: 27855385
[TBL] [Abstract][Full Text] [Related]
29. Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.
Carlson AM; Maurer MJ; Goergen KM; Kalli KR; Erskine CL; Behrens MD; Knutson KL; Block MS
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1730-5. PubMed ID: 23878295
[TBL] [Abstract][Full Text] [Related]
30. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
[TBL] [Abstract][Full Text] [Related]
31. Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.
Bednarska K; Król E; Głowacka E; Romanowicz H; Szyłło K; Klink M; Sułowska Z; Nowak M
Medicine (Baltimore); 2018 Mar; 97(12):e0180. PubMed ID: 29561432
[TBL] [Abstract][Full Text] [Related]
32. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
[TBL] [Abstract][Full Text] [Related]
33. Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study.
Braicu EI; Fotopoulou C; Van Gorp T; Richter R; Chekerov R; Hall C; Butz H; Castillo-Tong DC; Mahner S; Zeillinger R; Concin N; Vergote I; Sehouli J
Gynecol Oncol; 2013 Feb; 128(2):245-51. PubMed ID: 23178313
[TBL] [Abstract][Full Text] [Related]
34. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L
Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
Kristjansdottir B; Levan K; Partheen K; Sundfeldt K
Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789
[TBL] [Abstract][Full Text] [Related]
37. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.
Cho H; Hur HW; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
Cancer Immunol Immunother; 2009 Jan; 58(1):15-23. PubMed ID: 18414853
[TBL] [Abstract][Full Text] [Related]
38. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
Komatsu H; Oishi T; Itamochi H; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Sawada M; Wakahara M; Umekita Y; Harada T
Int J Gynecol Cancer; 2017 Sep; 27(7):1325-1332. PubMed ID: 28557832
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]